Mahi Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRAZODONE HYDROCHLORIDE USP, with a corresponding US DMF Number 39958.
Remarkably, this DMF maintains an Active status since its submission on July 03, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 08, 2024, and payment made on September 24, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II